Skip to content

    Tanfac Inds.

    506854
    Chemicals·16 May 2026
    Management Summary

    Tanfac Industries reported its highest ever revenues for Q4 and FY26, driven by successful capacity expansions in hydrofluoric acid and solar grade DHF. The company secured significant long-term contracts, providing strong growth visibility. However, profitability metrics like EBITDA and PAT saw compression due to raw material price increases and margin normalization, though management expects improvement with new product contributions.

    Highlights

    5
    • Revenue from operations grew 27.6% YoY to INR 711 crores in FY26 from INR 557 crores in FY25.

    • Successfully doubled hydrofluoric acid capacity from 15,000 MTPA to 30,000 MTPA with a low investment of INR 100 crores.

    • Commissioned 20,000 MTPA solar grade DHF project, making Tanfac the first and only manufacturer in India.

    • Secured orders worth INR 1,068 crores for solar grade DHF and INR 3,612 crores for fluorinated products, providing strong visibility.

    • Working capital cycle improved by 8 days to 91 days in FY26, reflecting enhanced operational efficiency.

    Concerns

    3
    • EBITDA margin declined to 16% in FY26 from 23% in FY25, attributed to margin normalization and increased raw material costs.

    • PAT decreased by 20.5% YoY to INR 70 crores in FY26 from INR 88 crores in FY25, impacted by lower operating profit and higher depreciation.

    • Sulphur prices increased from INR 30/kg in FY25 to INR 38-40/kg in FY26 due to geopolitical events, impacting gross margins despite pass-through with a lag.

    Key financials

    Single quarter

    06 metrics
    1. 01Revenue₹711 Cr+27.6%YoY
    2. 02EBITDA₹112 Cr-13.2%YoY
    3. 03EBITDA Margin16%
    4. 04PAT₹70 Cr-20.5%YoY
    5. 05PAT Margin10%

    Order Book

    high confidence

    Total Value

    ₹ 4,680 crores

    as of 2026-05-16

    quantified

    Execution

    executable over next 3.5 to 7 years

    Composition

    Mix2 products
    • Solar Grade DHF22.8%
    • Fluorinated Products (including HFC-32)77.2%

    Share of order book by product

    "The company has secured significant long-term contracts for solar grade DHF and other fluorinated products, providing strong revenue visibility for the coming years. HFC-32 contracts cover 65% of the proposed capacity, with a significant portion for exports."

    Source:
    Prepared remarks

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Capex

    ₹495 crores

    INR 100 crores from promoters by way of preferential allotment and remaining INR 300 crores by way of QIP and term debt for R-32 capex.

    Guidance & targets

    11
    CategoryTargetPriority
    Revenue
    Revenue Target
    INR 1,600-2,000 crores
    Medium
    Revenue
    Revenue Target
    INR 3,000-3,500 crores
    Medium
    Revenue
    Revenue from R-32 Capex
    INR 900-1,000 crores
    High
    Profitability
    EBITDA Margin
    15-18%
    Medium
    Profitability
    EBITDA Margin Increase (with R-32)
    3-4%
    Low
    Capacity
    HFC-32 Plant Commissioning
    Q3 FY27
    High
    Capacity
    Additional AHF Capacity Announcement
    30,000 tons
    Medium
    Capacity
    New HF and Solar Grade Plant Commissioning
    June '27
    High
    Capex
    Future Capex
    INR 500-700 crores
    Medium
    HFC-32
    HFC-32 Production Cost
    INR 240-280 per kg
    Medium
    HFC-32
    HFC-32 Payback Period
    less than four years
    High

    HFC-32 Plant Commissioning

    Q3 FY27
    CurrentUnder construction, progressing well
    TargetCommercial operations by Q3 FY27

    Why it matters

    Successful commissioning is key to realizing the projected INR 900-1,000 crores annual revenue and improving EBITDA margins.

    The project is progressing well and remains on track for the commissioning by Q3 in the year FY27.

    How to verify

    guidance_and_targets[category='Capacity'][metric='HFC-32 Plant Commissioning']

    Risks & concerns

    3
    RiskSeverity

    R-32 Quota Allocation Uncertainty

    The allocation of HFC-32 production quotas by the government in 2027 is critical for the new plant, with management relying on the stated policy but analysts raising concerns about competition from incumbents.Analyst acknowledged

    high

    Raw Material Price Volatility

    Increased sulphur prices due to geopolitical events impacted margins in FY26, though the company has a mechanism to pass on costs with a lag.Management acknowledged

    medium

    Project Execution and Commissioning Delays

    While management highlighted a strong track record of timely project execution, large-scale capex projects like HFC-32 and new AHF/solar grade DHF plants inherently carry execution risks.Management downplayed

    low

    Q&A highlights

    8

    “The quota, Harsh, will be decided in 2027 and it rests with the government. So, but the -- it will be decided in '27, but we have got a clean EC to manufacture this. So we are going ahead. And if you want details on quota, I think I can give it to you. You want details?”

    Analyst sought clarity on the R-32 quota, a critical factor for the new HFC-32 plant, and management explained the government's role and timeline for decision.

    asked by Harsh Shah

    3 min read6 chapters

    Detailed Narrative

    01

    Q4 & FY26 Financial Performance Overview

    Tanfac Industries achieved its highest ever quarterly revenue of INR 193 crores in Q4 FY26 and a record full-year revenue of INR 711 crores for FY26, representing a robust 27.6% year-on-year growth from INR 557 crores in FY25. Despite this top-line performance, the company experienced a decline in profitability, with EBITDA margin contracting to 16% in FY26 from 23% in FY25, and PAT falling to INR 70 crores from INR 88 crores. This was primarily attributed to the normalization of margins, increased raw material costs, and higher depreciation expenses.

    02

    Strategic Capacity Expansions and Market Positioning

    The company successfully completed significant capacity expansions, doubling its hydrofluoric acid capacity from 15,000 MTPA to 30,000 MTPA with a capital investment of approximately INR 100 crores. A major milestone was the commissioning of a 20,000 MTPA solar grade DHF project, establishing Tanfac as the first and only manufacturer of this product in India. These expansions reinforce Tanfac's position in high-growth sectors like solar photovoltaic and semiconductors, leveraging its integrated fluorochemical manufacturing platform.

    03

    Entry into Refrigerant Gases (HFC-32) and Future Growth Drivers

    Tanfac is making a strategic entry into the refrigerant gases segment with a planned capital expenditure of INR 495 crores, of which INR 405 crores is specifically for HFC-32. This investment will establish a 20,000 MTPA downstream fluorinated products manufacturing facility, expected to be commissioned by Q3 FY27. This move targets the rapidly growing global HFC-32 market, projected to reach 485 KT by 2030, and India's demand, which is anticipated to double to 45-50 KT in the next 4-5 years. The company has already secured contracts covering 65% of this proposed capacity.

    04

    Strong Order Book and Revenue Visibility

    The company has built a substantial order book, securing approximately INR 1,068 crores in solar grade DHF orders expected to be executed over the next 3.5 years. Additionally, long-term supplier arrangements for fluorinated products aggregate to INR 3,612 crores over a period of 5 to 7 years. These contracts provide strong revenue visibility and underscore customer confidence in Tanfac's capabilities and product quality. Management aims to achieve INR 1,600-2,000 crores in revenue by FY28 and INR 3,000-3,500 crores in the next five years.

    05

    Raw Material Cost Management and Margin Outlook

    Raw material costs, particularly for sulphur, increased from INR 30/kg in FY25 to INR 38-40/kg in FY26, primarily due to geopolitical factors in the West Asian region. While Tanfac passes on 100% of these cost increases to customers, there is a typical lag of 30-45 days. Management anticipates EBITDA margins to stabilize in the 15-18% range for existing businesses, with a potential 3-4% increase in margins once revenues from the new R-32 plant start contributing in the last quarter of the year.

    06

    R&D and Product Diversification Strategy

    Tanfac is actively focusing its R&D efforts on developing next-generation fluorinated products, including specialty fluoropolymers, battery chemical applications, and electronic grade chemicals. This strategy aims to cater to emerging high-growth and high-profitability sectors, ensuring a diversified product portfolio. The company also plans to strengthen backward integration capabilities through the expansion of HF and Sulphuric acid capacities to support its HFC-32 production.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.